Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NXGLW
Upturn stock ratingUpturn stock rating

NexGel Inc Warrant (NXGLW)

Upturn stock ratingUpturn stock rating
$0.29
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/16/2025: NXGLW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -91.96%
Avg. Invested days 20
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/16/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 0.52
52 Weeks Range 0.22 - 0.95
Updated Date 05/15/2025
52 Weeks Range 0.22 - 0.95
Updated Date 05/15/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.39

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -30.7%
Operating Margin (TTM) -27.69%

Management Effectiveness

Return on Assets (TTM) -20.77%
Return on Equity (TTM) -60.08%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 6447417
Shares Outstanding -
Shares Floating 6447417
Percent Insiders -
Percent Institutions -

ai summary icon Upturn AI SWOT

NexGel Inc Warrant

stock logo

Company Overview

overview logo History and Background

NexGel, Inc. is a hydrogel technology company. The warrants relate to ownership of the underlying stock. Detailed history is intertwined with NexGel's business operations, but specifically for the warrants, they represent a right to purchase stock at a predetermined price and time frame. Significant milestones would be tied to the issuance and expiration terms of the warrants.

business area logo Core Business Areas

  • Hydrogels: NexGel develops and manufactures high water content, cross-linked polymer networks. These are used in a range of applications including wound care, cosmetics, and diagnostics.

leadership logo Leadership and Structure

NexGel's leadership team would include a CEO, CFO, and potentially a Chief Scientific Officer or equivalent. The organizational structure will be typical of a small publicly traded company with functional departments such as R&D, manufacturing, sales, and marketing.

Top Products and Market Share

overview logo Key Offerings

  • Wound Care Hydrogels: NexGel's hydrogels are used in advanced wound dressings for burns, ulcers, and surgical sites. Market share data specific to NexGel is likely limited. Competitors include 3M (MMM), Smith & Nephew (SNN), and Convatec (CVA).
  • Cosmetic Hydrogels: Hydrogels incorporated into cosmetic and personal care products to deliver moisture and active ingredients. Market Share data is limited for NexGel. Key competitors include Ashland (ASH), BASF (BASFY), and Evonik (EVKIF).

Market Dynamics

industry overview logo Industry Overview

The hydrogel market is growing driven by demand in wound care, drug delivery, and personal care. The industry is competitive and innovation-focused.

Positioning

NexGel positions itself as a technology innovator in hydrogels, focusing on unique properties and applications. Its competitive advantage would lie in its proprietary formulations and manufacturing processes.

Total Addressable Market (TAM)

The global hydrogel market is estimated to be billions of dollars and growing. NexGel is positioning to capture market share with unique product offerings in their particular application segments.

Upturn SWOT Analysis

Strengths

  • Proprietary Hydrogel Technology
  • Strong focus on innovation
  • Diverse application potential
  • Experienced management team

Weaknesses

  • Limited financial resources
  • Small Market Share
  • Dependence on key partnerships
  • Limited brand recognition

Opportunities

  • Expanding into new markets
  • Developing strategic partnerships
  • Acquiring complementary technologies
  • Increasing demand for advanced wound care

Threats

  • Competition from larger companies
  • Regulatory hurdles
  • Economic downturns
  • Raw Material Price Increases

Competitors and Market Share

competitor logo Key Competitors

  • MMM
  • SNN
  • CVA
  • ASH
  • BASFY
  • EVKIF

Competitive Landscape

NexGel's advantages lie in its innovative hydrogel technology, but its disadvantages are related to scale and market presence compared to larger competitors.

Growth Trajectory and Initiatives

Historical Growth: Historical growth would depend on specific product launches and market penetration. Typically, this would involve analysis of revenue, market share, and profit.

Future Projections: Future growth projections would depend on analyst estimates for the hydrogel market and NexGel's ability to capture market share with its technology.

Recent Initiatives: Recent initiatives could include product development, partnership agreements, and expansion into new geographies.

Summary

NexGel Inc. Warrant's value is contingent on the performance of the underlying stock, NexGel, Inc. The company operates in the growing hydrogel market and has innovative technology, but faces stiff competition from larger, more established players. Its growth potential depends on successful commercialization and strategic partnerships. Investors should carefully consider the terms of the warrants and the financial health of NexGel Inc. before investing.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings
  • Industry Reports
  • Analyst Estimates

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About NexGel Inc Warrant

Exchange NASDAQ
Headquaters Langhorne, PA, United States
IPO Launch date 2021-12-22
CEO, President & Director Mr. Adam R. Levy
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 19
Full time employees 19

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.